Viral-Vectored Vaccines Market Report

China Viral-Vectored Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 27, 2023
  • PAGES：203
  • REPORT CODE：GMM1816067
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Viral-Vectored Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ceva Sante Animale (France)

    • Protein Sciences Corporation (US)

    • Lohmann Animal Health (US)

    • Bayer HealthCare AG (Germany)

    • Heska Corporation (US)

    • Boehringer Ingelheim GmbH (Germany)

    • Merial Ltd (US)

    • Virbac SA (France)

    • Indian Immunologicals Ltd (India)

    • Merck Animal Health (US)

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Viral-Vectored Vaccines Market Overview 2018-2029

    • 1.1 China Viral-Vectored Vaccines Industry Development Overview

    • 1.2 China Viral-Vectored Vaccines Industry Development History

    • 1.3 China Viral-Vectored Vaccines Industry Market Size (2018-2029)

    • 1.4 China Viral-Vectored Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Viral-Vectored Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Viral-Vectored Vaccines Market Analysis by Region

      • 1.6.1 North China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Viral-Vectored Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Viral-Vectored Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Viral-Vectored Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Viral-Vectored Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Viral-Vectored Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Viral-Vectored Vaccines Industry Development

    Chapter 3 Viral-Vectored VaccinesIndustry Chain Analysis

    • 3.1 Viral-Vectored Vaccines Industry Chain

    • 3.2 Viral-Vectored Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Viral-Vectored Vaccines Market

    • 3.3 Viral-Vectored Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Viral-Vectored Vaccines Market

    Chapter 4 China Viral-Vectored Vaccines Market, by Type

    • 4.1 China Viral-Vectored Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Viral-Vectored Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Viral-Vectored Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 1

      • 4.5.2 China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 2

      • 4.5.3 China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 3

    Chapter 5 China Viral-Vectored Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Viral-Vectored Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Viral-Vectored Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Viral-Vectored Vaccines Market Size and Growth Rate of Application 1

      • 5.5.2 China Viral-Vectored Vaccines Market Size and Growth Rate of Application 2

      • 5.5.3 China Viral-Vectored Vaccines Market Size and Growth Rate of Application 3

    Chapter 6 China Viral-Vectored Vaccines Market, by Region

    • 6.1 China Viral-Vectored Vaccines Production Volume and Production Value, by Region

    • 6.2 China Viral-Vectored Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Viral-Vectored Vaccines Market Analysis

    • 7.1 North China Viral-Vectored Vaccines Market, by Type

    • 7.2 North China Viral-Vectored Vaccines Market, by Application

    Chapter 8 Central China Viral-Vectored Vaccines Market Analysis

    • 8.1 Central China Viral-Vectored Vaccines Market, by Type

    • 8.2 Central China Viral-Vectored Vaccines Market, by Application

    Chapter 9 South China Viral-Vectored Vaccines Market Analysis

    • 9.1 South China Viral-Vectored Vaccines Market, by Type

    • 9.2 South China Viral-Vectored Vaccines Market, by Application

    Chapter 10 East China Viral-Vectored Vaccines Market Analysis

    • 10.1 East China Viral-Vectored Vaccines Market, by Type

    • 10.2 East China Viral-Vectored Vaccines Market, by Application

    Chapter 11 Northeast China Viral-Vectored Vaccines Market Analysis

    • 11.1 Northeast China Viral-Vectored Vaccines Market, by Type

    • 11.2 Northeast China Viral-Vectored Vaccines Market, by Application

    Chapter 12 Southwest China Viral-Vectored Vaccines Market Analysis

    • 12.1 Southwest China Viral-Vectored Vaccines Market, by Type

    • 12.2 Southwest China Viral-Vectored Vaccines Market, by Application

    Chapter 13 Northwest China Viral-Vectored Vaccines Market Analysis

    • 13.1 Northwest China Viral-Vectored Vaccines Market, by Type

    • 13.2 Northwest China Viral-Vectored Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ceva Sante Animale (France)

        • 14.1.1 Ceva Sante Animale (France) Company Profile

        • 14.1.2 Ceva Sante Animale (France) Viral-Vectored Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Protein Sciences Corporation (US)

        • 14.2.1 Protein Sciences Corporation (US) Company Profile

        • 14.2.2 Protein Sciences Corporation (US) Viral-Vectored Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Lohmann Animal Health (US)

        • 14.3.1 Lohmann Animal Health (US) Company Profile

        • 14.3.2 Lohmann Animal Health (US) Viral-Vectored Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer HealthCare AG (Germany)

        • 14.4.1 Bayer HealthCare AG (Germany) Company Profile

        • 14.4.2 Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Heska Corporation (US)

        • 14.5.1 Heska Corporation (US) Company Profile

        • 14.5.2 Heska Corporation (US) Viral-Vectored Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Boehringer Ingelheim GmbH (Germany)

        • 14.6.1 Boehringer Ingelheim GmbH (Germany) Company Profile

        • 14.6.2 Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merial Ltd (US)

        • 14.7.1 Merial Ltd (US) Company Profile

        • 14.7.2 Merial Ltd (US) Viral-Vectored Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Virbac SA (France)

        • 14.8.1 Virbac SA (France) Company Profile

        • 14.8.2 Virbac SA (France) Viral-Vectored Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Indian Immunologicals Ltd (India)

        • 14.9.1 Indian Immunologicals Ltd (India) Company Profile

        • 14.9.2 Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Merck Animal Health (US)

        • 14.10.1 Merck Animal Health (US) Company Profile

        • 14.10.2 Merck Animal Health (US) Viral-Vectored Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Viral-Vectored Vaccines Industry Research Conclusions

    • 15.2 Viral-Vectored Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Viral-Vectored Vaccines Industry Market Size (2018-2029)

    • Figure China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Viral-Vectored Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Viral-Vectored Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Viral-Vectored Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Viral-Vectored Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Viral-Vectored Vaccines Market Share by Type in 2018

    • Figure China Viral-Vectored Vaccines Market Share by Type in 2023

    • Figure China Viral-Vectored Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Viral-Vectored Vaccines Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Viral-Vectored Vaccines Market Share by Application in 2018

    • Figure China Viral-Vectored Vaccines Market Share by Application in 2023

    • Figure China Viral-Vectored Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Viral-Vectored Vaccines Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Viral-Vectored Vaccines Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Viral-Vectored Vaccines Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Viral-Vectored Vaccines Production Volume by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Viral-Vectored Vaccines Production Volume Share by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Production Value by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Production Value Share by Region (2018-2023)

    • Figure China Viral-Vectored Vaccines Production Value Share by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Sales Volume by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Viral-Vectored Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Sales Value by Region (2018-2023)

    • Table China Viral-Vectored Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Viral-Vectored Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table North China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table North China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table Central China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table South China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table South China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table East China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table East China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Viral-Vectored Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Viral-Vectored Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Viral-Vectored Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Viral-Vectored Vaccines Sales Volume Share by Application (2018-2023)

    • Table Ceva Sante Animale (France) Company Profile

    • Table Ceva Sante Animale (France) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Protein Sciences Corporation (US) Company Profile

    • Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Lohmann Animal Health (US) Company Profile

    • Table Lohmann Animal Health (US) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare AG (Germany) Company Profile

    • Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Heska Corporation (US) Company Profile

    • Table Heska Corporation (US) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH (Germany) Company Profile

    • Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merial Ltd (US) Company Profile

    • Table Merial Ltd (US) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Virbac SA (France) Company Profile

    • Table Virbac SA (France) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Indian Immunologicals Ltd (India) Company Profile

    • Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merck Animal Health (US) Company Profile

    • Table Merck Animal Health (US) Viral-Vectored Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US